Clopra and Nateglinide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clopra (metoclopramide hydrochloride) and Nateglinide (nateglinide). Common drug interactions include chronic kidney disease among females and neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Clopra and Nateglinide. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Clopra?

Clopra has active ingredients of metoclopramide hydrochloride. eHealthMe is studying from 81,430 Clopra users. Check the latest studies of Clopra.

What is Nateglinide?

Nateglinide has active ingredients of nateglinide. It is often used in type 2 diabetes. eHealthMe is studying from 1,771 Nateglinide users. Check the latest studies of Nateglinide.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

12 people who take Clopra and Nateglinide together, and have interactions are studied.

Clopra and Nateglinide drug interactions.

What are the common drug interactions of Clopra and Nateglinide, by gender? *:

female:

Chronic kidney disease
Renal failure (kidney dysfunction)
Cholecystitis (infection of gallbladder)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
Fatigue (feeling of tiredness)
Gallbladder non-functioning
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Injury
Mucormycosis (a rare infection caused by organisms that belong to a group of fungi called mucoromycotina)

male:

Neutropenia (an abnormally low number of neutrophils)
Acute graft versus host disease (acute complication following an allogeneic tissue/blood transplant)
Hiccups (an involuntary spasm of the diaphragm and respiratory organs, with a sudden closure of the glottis and a sound like a cough)
Hospitalisation
Hyperglycaemia (high blood sugar)
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Impaired gastric emptying
Infection

What are the common drug interactions of Clopra and Nateglinide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Chronic kidney disease
Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Injection site erythema (redness at injection site)
Injection site pruritus (severe itching at injection site)
Malaise (a feeling of general discomfort or uneasiness)
Mucormycosis (a rare infection caused by organisms that belong to a group of fungi called mucoromycotina)
Nausea (feeling of having an urge to vomit)
Renal failure (kidney dysfunction)
Vomiting

50-59:

Acute graft versus host disease (acute complication following an allogeneic tissue/blood transplant)
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Antithrombin iii decreased
Blood pressure decreased
Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
Chronic kidney disease
Haematuria (presence of blood in urine)
Hiccups (an involuntary spasm of the diaphragm and respiratory organs, with a sudden closure of the glottis and a sound like a cough)
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection)

60+:

Neutropenia (an abnormally low number of neutrophils)
Cholecystitis (infection of gallbladder)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Impaired gastric emptying
Infection
Injury
Lymph gland infection
Lymphadenitis (inflammation or enlargement of a lymph node)
Renal failure (kidney dysfunction)
Renal injury (kidney injury)

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 25.00%
Sepsis (a severe blood infection that can lead to organ failure and death): 2 people, 16.67%
Diabetes: 2 people, 16.67%
Nausea (feeling of having an urge to vomit): 2 people, 16.67%
Indigestion: 2 people, 16.67%
Pancreatogenous Diabetes: 2 people, 16.67%
Allergies: 1 person, 8.33%
Back Pain: 1 person, 8.33%
Birth Control: 1 person, 8.33%
Bleeding Disorders: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Clopra and Nateglinide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously